QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report “Equine Chorionic Gonadotropin (eCG)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”. Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Equine Chorionic Gonadotropin (eCG) market, including market size, share, demand, industry development status, and forecasts for the next few years. The global market for Equine Chorionic Gonadotropin (eCG) was estimated to be worth US$ 269 million in 2024 and is forecast to a readjusted size of US$ 374 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031. 【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】 https://www.qyresearch.com/reports/4941024/equine-chorionic-gonadotropin--ecg According to the new market research report “Equine Chorionic Gonadotropin (eCG) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”, published by QYResearch, the global Equine Chorionic Gonadotropin (eCG) market size is projected to reach USD 0.37 billion by 2031, at a CAGR of 4.7% during the forecast period. Equine Chorionic Gonadotropin (eCG) Market: Enhancing Livestock Reproductive Efficiency Introduction to eCG Equine Chorionic Gonadotropin (eCG), also known as Pregnant Mare Serum Gonadotropin (PMSG), is a vital hormone extracted from the blood of pregnant mares. It possesses unique dual biological activity, mimicking both Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) in non-equine species. This makes it an indispensable tool in modern animal husbandry for synchronizing estrus cycles, inducing superovulation, and treating infertility in livestock such as pigs, cattle, and goats, thereby significantly enhancing reproductive efficiency. Market Outlook and Forecast Driven by the global need to optimize livestock production, the eCG market is on a steady growth path. The market size is projected to reach USD 0.37 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 4.7% during the forecast period. This growth is underpinned by the intensification of global farming and the continuous pursuit of higher reproductive yields. Competitive Landscape and Key Players The global eCG market is relatively consolidated, with the top five manufacturers commanding approximately 74.0% of the market revenue in 2024. Leading companies include: MSD Animal Health (Merck Animal Health): A global leader with a comprehensive portfolio, leveraging significant R&D and manufacturing scale. Ceva Santé Animale: A major France-based, veterinarian-led company with strong global commercial operations and strategic growth initiatives. Ningbo Sansheng Biological Technology Co., Ltd.: A prominent Chinese national high-tech enterprise and a leader in the domestic animal reproductive hormone market, actively expanding its international presence. Market Segmentation By Product Type: The 5000 IU/Units dosage segment is the market leader, holding a dominant share of 40%, reflecting its standard use in common livestock synchronization protocols. By Application: The Pigs segment is the largest application area, accounting for 64% of the market. This highlights eCG's critical role in managing the reproductive cycles of large-scale swine operations to ensure consistent farrowing and production. By Region: Europe stands as the largest consumer market, representing about 40% of global consumption, indicative of its advanced and intensive livestock farming sector. Market Drivers Demand for Efficient Livestock Production: Rising global consumption of meat and dairy products necessitates improved reproductive rates and herd productivity, sustaining core demand for eCG. Technological Advancements in Biotechnology: Ongoing improvements in extraction, purification, and standardization processes are enhancing the purity, efficacy, and reliability of eCG products. Expansion of Assisted Reproductive Technologies (ART): The growing adoption of techniques like in vitro fertilization (IVF) and embryo transfer in both commercial farming and research further propels the use of eCG. Growth in Emerging Markets: The intensification and modernization of livestock farming in emerging economies present significant new avenues for market expansion. Market Challenges and Restraints Ethical and Animal Welfare Concerns: The source of eCG (pregnant mare blood) faces increasing scrutiny from animal welfare groups, potentially affecting public perception and regulatory approvals. Competition from Synthetic Alternatives: The development and potential adoption of recombinant or synthetic gonadotropins pose a long-term competitive threat to natural-source eCG. Complex Regulatory Environments: Navigating diverse and sometimes stringent veterinary drug registration requirements across different countries increases the cost and complexity of market access. Supply Chain Consistency: Ensuring a consistent, high-quality, and ethically sourced supply of raw material (mare serum) remains a critical challenge for the industry. The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively. The Equine Chorionic Gonadotropin (eCG) market is segmented as below: By Company MSD Animal Health Ceva Santé Animale Syntex SA Bioveta Ningbo Sansheng Biological Technology Ningbo Second Hormone Factory Chifeng Bo-en Pharmaceutical Guangzhou Vbio-Pharma JALLY Ningbo Creator Animal Pharmaceutical Segment by Type 1000IU/Units 5000IU/Units Others Segment by Application Pigs Cattles Sheeps Horses Other Animals Each chapter of the report provides detailed information for readers to further understand the Equine Chorionic Gonadotropin (eCG) market: Chapter 1: Introduces the report scope of the Equine Chorionic Gonadotropin (eCG) report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2020-2031) Chapter 2: Detailed analysis of Equine Chorionic Gonadotropin (eCG) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2020-2025) Chapter 3: Provides the analysis of various Equine Chorionic Gonadotropin (eCG) market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2020-2031) Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2020-2031) Chapter 5: Sales, revenue of Equine Chorionic Gonadotropin (eCG) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2020-2031) Chapter 6: Sales, revenue of Equine Chorionic Gonadotropin (eCG) in country level. It provides sigmate data by Type, and by Application for each country/region.(2020-2031) Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2020-2025) Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 9: Conclusion. Benefits of purchasing QYResearch report: Competitive Analysis: QYResearch provides in-depth Equine Chorionic Gonadotropin (eCG) competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge. Industry Analysis: QYResearch provides Equine Chorionic Gonadotropin (eCG) comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis. and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions. Market Size: QYResearch provides Equine Chorionic Gonadotropin (eCG) market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development. Other relevant reports of QYResearch: Global Equine Chorionic Gonadotropin (eCG) Market Outlook, InDepth Analysis & Forecast to 2031 Global Equine Chorionic Gonadotropin (eCG) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031 Global Equine Chorionic Gonadotropin (eCG) Market Research Report 2025 Equine Chorionic Gonadotropin (eCG)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Outlook, InDepth Analysis & Forecast to 2031 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031 Equine Chorionic Gonadotropin (eCG) for Injection- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Research Report 2025 About Us： QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world. Contact Us: If you have any queries regarding this report or if you would like further information, please contact us: QY Research Inc. Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States EN: https://www.qyresearch.com Email: global@qyresearch.com Tel: 001-626-842-1666(US) JP: https://www.qyresearch.co.jp